If you have any questions about our products or services, please fill out the message below and we will give you feedback as soon as possible.
Ramucirumab (LY3009806, IMC-1121B, trade name Cyramza) is a fully human monoclonal antibody (IgG1) developed for the treatment ofsolid tumors. This drug was developed by ImClone Systems Inc.
If you have any questions about our products or services, please fill out the message below and we will give you feedback as soon as possible.